CKD stage 3 to 5 had an adjusted HR of 1.23 (95% CI: 1.16–1.30, p < 0.001), cancer had an adjusted HR of 1.17 (95% CI: 1.11–1.24, p < 0.001), and serum albumin < 4 g/dL had an adjusted HR of 1.10 (95% CI: 1.04–1.17, p = 0.001). This evidence concerns the gene ALB and cancer.